PMC:7544943 / 19898-20034 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T2","span":{"begin":72,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Solubility acts as a driving force to attain high drug concentration in blood for therapeutic effectiveness (Bergström \u0026 Larsson, 2018)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T21","span":{"begin":72,"end":77},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma9670"}],"text":"Solubility acts as a driving force to attain high drug concentration in blood for therapeutic effectiveness (Bergström \u0026 Larsson, 2018)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T89","span":{"begin":19,"end":20},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T90","span":{"begin":72,"end":77},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T91","span":{"begin":72,"end":77},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T92","span":{"begin":130,"end":134},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"}],"text":"Solubility acts as a driving force to attain high drug concentration in blood for therapeutic effectiveness (Bergström \u0026 Larsson, 2018)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T181","span":{"begin":0,"end":136},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Solubility acts as a driving force to attain high drug concentration in blood for therapeutic effectiveness (Bergström \u0026 Larsson, 2018)."}

{"project":"2_test","denotations":[{"id":"32938313-29421301-56197391","span":{"begin":130,"end":134},"obj":"29421301"}],"text":"Solubility acts as a driving force to attain high drug concentration in blood for therapeutic effectiveness (Bergström \u0026 Larsson, 2018)."}